James R Cerhan (James Cerhan)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 119

Top Venues

Blood advances

Blood cancer journal

American journal of hematology

Blood

Mayo Clinic Rochester

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mayo Clinic Rochester

United States

Professor :: Health Sciences Research

Publications

Allison M Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew John Maurer, Amy Ayers, Brad S Kahl, Peter Martin, Jonathon B Cohen, Carla Casulo, Izidore S Lossos, Umar Farooq, Sabarish Ayyappan, Tanner Reicks, Thomas M Habermann, Thomas E Witzig, Christopher R Flowers, James R Cerhan, Loretta J Nastoupil, Grzegorz S Nowakowski
Defining primary refractory large B-cell lymphoma. Blood advances 8 (13) (2024)
Kamilia N Moalem, Juan Pablo Alderuccio, Côme Bommier, Thomas Habermann, Brian L Link, James R Cerhan, Jorge Florindez, Izidore S Lossos
Transformation of marginal zone lymphoma to Hodgkin lymphoma. Blood advances 8 (17) (2024)
Salma B Abdelbaky, Brian Giacopelli, Kari G Rabe, Kyoko Yamaguchi, Yue-Zhong Wu, Huihuang Yan, Tait D Shanafelt, Sameer A Parikh, Wei Ding, Paul Joseph Hampel, Sochilt Brown, James R Cerhan, Celine M Vachon, Neil E Kay, Curtis A Hanson, Alexander S Parker, Esteban Braggio, Susan L Slager, Christopher C Oakes
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature. Blood 143 (17) (2024)
Allison M Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew John Maurer, Amy Ayers, Brad S Kahl, Peter Martin, Jonathon B Cohen, Carla Casulo, Izidore S Lossos, Umar Farooq, Sabarish Ayyappan, Tanner Reicks, Thomas M Habermann, Thomas E Witzig, Christopher R Flowers, James R Cerhan, Loretta J Nastoupil, Grzegorz S Nowakowski
Defining primary refractory large B-cell lymphoma. Blood advances 8 (13) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
Brooj Abro, Matthew John Maurer, Thomas M Habermann, W Richard Burack, Jennifer R Chapman, Jonathon B Cohen, Jonathan W Friedberg, Giorgio Ga Inghirami, Brad S Kahl, Melissa C Larson, Brian L Link, Izidore S Lossos, Peter Martin, Timothy McDonnell, Loretta J Nastoupil, Shaun Riska, Sergei I Syrbu, Francisco Vega, Kiran Vij, Christopher R Flowers, James R Cerhan, David L Jaye, Andrew L Feldman
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO Cohort Study analysis. Blood (2024)
Kamilia N Moalem, Juan Pablo Alderuccio, Côme Bommier, Thomas Habermann, Brian L Link, James R Cerhan, Jorge Florindez, Izidore S Lossos
Transformation of marginal zone lymphoma to Hodgkin lymphoma. Blood advances 8 (17) (2024)
Kamilia N Moalem, Juan Pablo Alderuccio, Côme Bommier, Thomas H Habermann, Brian L Link, James R Cerhan, Jorge Antenor Florindez, Izidore S Lossos
Transformation of Marginal Zone Lymphoma to Hodgkin Lymphoma. Blood advances (2024)
Geffen Kleinstern, Nicholas J Boddicker, Daniel R O'Brien, Cristine Allmer, Kari G Rabe, Aaron D Norman, Rosalie G Waller, Huihuang Yan, Tao Ma, Timothy G Call, Laura Bruins, Sochilt Brown, Cecilia Bonolo de Campos, Curtis A Hanson, Jose F Leis, Wei Ding, Celine M Vachon, Neil E Kay, Christopher C Oakes, Alexander S Parker, Danielle M Brander, J Brice Weinberg, Richard R Furman, Tait D Shanafelt, James R Cerhan, Sameer A Parikh, Esteban Braggio, Susan L Slager
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis. Blood advances 8 (9) (2024)
Vanessa L Kronzer, Jeffrey A Sparks, Soumya Raychaudhuri, James R Cerhan
Low-frequency and rare genetic variants associated with rheumatoid arthritis risk. Nature reviews. Rheumatology (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology (2024)
Geffen Kleinstern, Nicholas J Boddicker, Daniel R O'Brien, Cristine Allmer, Kari G Rabe, Aaron D Norman, Rosalie G Waller, Huihuang Yan, Tao Ma, Timothy G Call, Laura Bruins, Sochilt Brown, Cecilia Bonolo de Campos, Curtis A Hanson, Jose F Leis, Wei Ding, Celine M Vachon, Neil E Kay, Christopher C Oakes, Alexander Parker, Danielle M Brander, J Brice Weinberg, Richard R Furman, Tait D Shanafelt, James R Cerhan, Sameer A Parikh, Esteban Braggio, Susan L Slager
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis (HCMBL). Blood advances (2024)
Arushi Khurana, Raphael Mwangi, Loretta J Nastoupil, Patrick M Reagan, Umar Farooq, Jason T Romancik, Timothy McDonnell, Shaun Riska, Izidore S Lossos, Brad S Kahl, Peter Martin, Thomas E Witzig, James R Cerhan, Christopher R Flowers, Grzegorz S Nowakowski, Matthew John Maurer
Evaluating Lab-Based Eligibility Criteria by Race/Ethnicity in Clinical Trials of Diffuse Large B-Cell Lymphoma. Blood advances (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Julia E Wiedmeier, Chantal E McCabe, Daniel R O'Brien, Erik Jessen, Cecilia Bonolo de Campos, Nicholas J Boddicker, Rosalie Griffin, Cristine Allmer, Kari G Rabe, James R Cerhan, Sameer A Parikh, Neil E Kay, Huihuang Yan, Daniel L Van Dyke, Susan L Slager, Esteban Braggio
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations. Cancers 16 (13) (2024)
Arushi Khurana, Raphael Mwangi, Loretta J Nastoupil, Patrick M Reagan, Umar Farooq, Jason T Romancik, Timothy J McDonnell, Shaun M Riska, Izidore S Lossos, Brad S Kahl, Peter Martin, Thomas E Witzig, James R Cerhan, Christopher R Flowers, Grzegorz S Nowakowski, Matthew John Maurer
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL. Blood advances 8 (16) (2024)
Salma B Abdelbaky, Brian Giacopelli, Kari G Rabe, Kyoko Yamaguchi, Yue-Zhong Wu, Huihuang Yan, Tait D Shanafelt, Sameer A Parikh, Wei Ding, Paul Joseph Hampel, Sochilt Brown, James R Cerhan, Celine M Vachon, Neil E Kay, Curtis A Hanson, Alexander S Parker, Esteban Braggio, Susan L Slager, Christopher C Oakes
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature. Blood 143 (17) (2024)
Salma Abdelbaky, Brian Giacopelli, Kari G Rabe, Kyoko Yamaguchi, Yue-Zhong Wu, Huihuang Yan, Tait D Shanafelt, Sameer A Parikh, Wei Ding, Paul Joseph Hampel, Sochilt Brown, James R Cerhan, Celine M Vachon, Neil E Kay, Curtis A Hanson, Alexander Parker, Esteban Braggio, Susan L Slager, Christopher C Oakes
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature. Blood (2024)
Matthew E Stokes, Kerstin Wenzl, C Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew John Maurer, Nicholas Stong, Yumi Nakayama, Lei Wu, Hsiling Chiu, Ann Polonskaia, Samuel A Danziger, Fadi Towfic, Joel Parker, Rebecca L King, Brian K Link, Susan L Slager, Vivekananda Sarangi, Yan W Asmann, Joseph P Novak, Akshay Sudhindra, Stephen M Ansell, Thomas M Habermann, Patrick R Hagner, Grzegorz S Nowakowski, James R Cerhan, Anne J Novak, Anita K Gandhi
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation. Nature communications 15 (1) (2024)
Allison M Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew John Maurer, Amy Ayers, Brad S Kahl, Peter Martin, Jonathon B Cohen, Carla Casulo, Izidore S Lossos, Umar Farooq, Sabarish Ayyappan, Tanner Wayne Reicks, Thomas M Habermann, Thomas E Witzig, Christopher R Flowers, James R Cerhan, Loretta J Nastoupil, Grzegorz S Nowakowski
Defining Primary Refractory Large B-cell Lymphoma. Blood advances (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, M Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared to R-CHOP. Blood advances (2024)
Geffen Kleinstern, Nicholas J Boddicker, Daniel R O'Brien, Cristine Allmer, Kari G Rabe, Aaron D Norman, Rosalie G Waller, Huihuang Yan, Tao Ma, Timothy G Call, Laura Bruins, Sochilt Brown, Cecilia Bonolo de Campos, Curtis A Hanson, Jose F Leis, Wei Ding, Celine M Vachon, Neil E Kay, Christopher C Oakes, Alexander Parker, Danielle M Brander, J Brice Weinberg, Richard R Furman, Tait D Shanafelt, James R Cerhan, Sameer A Parikh, Esteban Braggio, Susan L Slager
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis (HCMBL). Blood advances (2024)
Geffen Kleinstern, Nicholas J Boddicker, Daniel R O'Brien, Cristine Allmer, Kari G Rabe, Aaron D Norman, Rosalie G Waller, Huihuang Yan, Tao Ma, Timothy G Call, Laura Bruins, Sochilt Brown, Cecilia Bonolo de Campos, Curtis A Hanson, Jose F Leis, Wei Ding, Celine M Vachon, Neil E Kay, Christopher C Oakes, Alexander Parker, Danielle M Brander, J Brice Weinberg, Richard R Furman, Tait D Shanafelt, James R Cerhan, Sameer A Parikh, Esteban Braggio, Susan L Slager
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis (HCMBL). Blood advances (2024)
Bryan A Vallejo, Ahmed Ansari, Sameer A Parikh, Sara J Achenbach, Kari G Rabe, Aaron D Norman, Janet E Olson, Neil E Kay, Esteban Braggio, Curtis A Hanson, Celine M Vachon, James R Cerhan, Cristian L Baum, Tait D Shanafelt, Susan L Slager
Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Geffen Kleinstern, Nicholas J Boddicker, Daniel R O'Brien, Cristine Allmer, Kari G Rabe, Aaron D Norman, Rosalie G Waller, Huihuang Yan, Tao Ma, Timothy G Call, Laura Bruins, Sochilt Brown, Cecilia Bonolo de Campos, Curtis A Hanson, Jose F Leis, Wei Ding, Celine M Vachon, Neil E Kay, Christopher C Oakes, Alexander S Parker, Danielle M Brander, J Brice Weinberg, Richard R Furman, Tait D Shanafelt, James R Cerhan, Sameer A Parikh, Esteban Braggio, Susan L Slager
Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis. Blood advances 8 (9) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Salma Abdelbaky, Brian Giacopelli, Kari G Rabe, Kyoko Yamaguchi, Yue-Zhong Wu, Huihuang Yan, Tait D Shanafelt, Sameer A Parikh, Wei Ding, Paul Joseph Hampel, Sochilt Brown, James R Cerhan, Celine M Vachon, Neil E Kay, Curtis A Hanson, Alexander Parker, Esteban Braggio, Susan L Slager, Christopher C Oakes
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature. Blood (2024)
Vanessa L Kronzer, Jeffrey A Sparks, Soumya Raychaudhuri, James R Cerhan
Low-frequency and rare genetic variants associated with rheumatoid arthritis risk. Nature reviews. Rheumatology 20 (5) (2024)
Matthew E Stokes, Kerstin Wenzl, C Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew John Maurer, Nicholas Stong, Yumi Nakayama, Lei Wu, Hsiling Chiu, Ann Polonskaia, Samuel A Danziger, Fadi Towfic, Joel Parker, Rebecca L King, Brian K Link, Susan L Slager, Vivekananda Sarangi, Yan W Asmann, Joseph P Novak, Akshay Sudhindra, Stephen M Ansell, Thomas M Habermann, Patrick R Hagner, Grzegorz S Nowakowski, James R Cerhan, Anne J Novak, Anita K Gandhi
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation. Nature communications 15 (1) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
Matthew E Stokes, Kerstin Wenzl, C Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew John Maurer, Nicholas Stong, Yumi Nakayama, Lei Wu, Hsiling Chiu, Ann Polonskaia, Samuel A Danziger, Fadi Towfic, Joel Parker, Rebecca L King, Brian K Link, Susan L Slager, Vivekananda Sarangi, Yan W Asmann, Joseph P Novak, Akshay Sudhindra, Stephen M Ansell, Thomas M Habermann, Patrick R Hagner, Grzegorz S Nowakowski, James R Cerhan, Anne J Novak, Anita K Gandhi
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation. Nature communications 15 (1) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, Maria Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP. Blood advances 8 (9) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, M Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared to R-CHOP. Blood advances (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Kurt S Bantilan, Alexandra N Smith, Matthew John Maurer, Julie Teruya-Feldstein, Matthew J Matasar, Alison J Moskowitz, David J Straus, Ariela Noy, M Lia Palomba, Steven M Horwitz, Paul A Hamlin, Carol S Portlock, James R Cerhan, Thomas M Habermann, Gilles Andre Salles, Grzegorz S Nowakowski, Craig H Moskowitz, Andrew D Zelenetz
Matched control analysis suggests R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared to R-CHOP. Blood advances (2024)
Salma Abdelbaky, Brian Giacopelli, Kari G Rabe, Kyoko Yamaguchi, Yue-Zhong Wu, Huihuang Yan, Tait D Shanafelt, Sameer A Parikh, Wei Ding, Paul Joseph Hampel, Sochilt Brown, James R Cerhan, Celine M Vachon, Neil E Kay, Curtis A Hanson, Alexander Parker, Esteban Braggio, Susan L Slager, Christopher C Oakes
Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature. Blood (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
Allison M Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew John Maurer, Amy Ayers, Brad S Kahl, Peter Martin, Jonathon B Cohen, Carla Casulo, Izidore S Lossos, Umar Farooq, Sabarish Ayyappan, Tanner Reicks, Thomas M Habermann, Thomas E Witzig, Christopher R Flowers, James R Cerhan, Loretta J Nastoupil, Grzegorz S Nowakowski
Defining primary refractory large B-cell lymphoma. Blood advances 8 (13) (2024)
Julia E Wiedmeier, Chantal E McCabe, Daniel R O'Brien, Erik Jessen, Cecilia Bonolo de Campos, Nicholas J Boddicker, Rosalie Griffin, Cristine Allmer, Kari G Rabe, James R Cerhan, Sameer A Parikh, Neil E Kay, Huihuang Yan, Daniel L Van Dyke, Susan L Slager, Esteban Braggio
Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations. Cancers 16 (13) (2024)
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, Allison M Bock, Sana Khan, Melissa A Hopper, Jordan Edward Krull, Abigail R Dropik, Janek S Walker, Vivekananda Sarangi, Raphael Mwangi, Maria Ortiz, Nicholas Stong, C Chris Huang, Matthew John Maurer, Lisa Rimsza, Brian K Link, Susan L Slager, Yan Asmann, Patrizia Mondello, Ryan Morin, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Andrew L Feldman, Rebecca L King, Grzegorz S Nowakowski, James R Cerhan, Anita K Gandhi, Anne J Novak
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL. Blood cancer journal 14 (1) (2024)
Suzette J Bielinski, Licy L Yanes Cardozo, Paul Y Takahashi, Nicholas B Larson, Alexandra Castillo, Alana Podwika, Eleanna De Filippis, Valentina Hernandez, Gouri J Mahajan, Crystal Gonzalez, null Shubhangi, Paul A Decker, Jill M Killian, Janet E Olson, Jennifer L St Sauver, Pankaj Shah, Adrian Vella, Euijung Ryu, Hongfang Liu, Gailen D Marshall, James R Cerhan, Davinder Singh, Richard L Summers
Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk Patients. The Journal of clinical endocrinology and metabolism (2023)
Cristina Correia, Matthew John Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, James R Cerhan, Susan L Slager, Thomas E Witzig, Bruce W Eckloff, Hu Li, Grzegorz S Nowakowski, Scott H Kaufmann
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era. Blood cancer journal 13 (1) (2023)
Juan Pablo Alderuccio, Isildinha M Reis, Jean L Koff, Melissa C Larson, Dai Chihara, Wei Zhao, Sara Haddadi, Thomas M Habermann, Peter Martin, Jennifer Chapman, Christopher S Strouse, Brad S Kahl, Jonathon B Cohen, Jonathan W Friedberg, James R Cerhan, Christopher R Flowers, Izidore S Lossos
Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma. Blood (2023)
Côme Bommier, Emanuele Zucca, Sylvie Chevret, Annarita Conconi, Grzegorz S Nowakowski, Matthew John Maurer, James R Cerhan, Catherine Thieblemont, Jerome Lambert
Early Complete Response as Validated Surrogate Marker in Extranodal Marginal Zone Lymphoma Systemic Therapy. Blood (2023)
Nicholas J Boddicker, Sameer A Parikh, Aaron D Norman, Kari G Rabe, Rosalie Griffin, Timothy G Call, Dennis P Robinson, Janet E Olson, Angela Dispenzieri, Vincent Rajkumar, Shaji K Kumar, Neil E Kay, Curtis A Hanson, James R Cerhan, David L Murray, Esteban Braggio, Tait D Shanafelt, Celine M Vachon, Susan L Slager
Relationship among three common hematological premalignant conditions. Leukemia (2023)
Rosalie G Waller, Julia Erin Wiedmeier-Nutor, Sameer A Parikh, Chantal E McCabe, Daniel R O'Brien, Nicholas J Boddicker, Geffen Kleinstern, Kari G Rabe, Laura Bruins, Sochilt Brown, Cecilia Bonolo de Campos, Wei Ding, Jose F Leis, Paul Joseph Hampel, Timothy G Call, Daniel Van Dyke, Neil E Kay, James R Cerhan, Huihuang Yan, Susan L Slager, Esteban Braggio
Differential prognosis of single and multiple TP53 abnormalities in high count MBL and untreated CLL. Blood advances (2023)
Allison M Bock, Jennifer Jane Gile, Melissa C Larson, Kittika Poonsombudlert, Reema K Tawfiq, Seth Maliske, Matthew John Maurer, Brian F Kabat, Jonas Paludo, David J Inwards, Sabarish Ayyappan, Brian K Link, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski, James R Cerhan, Umar Farooq, Yucai Wang
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study. Blood cancer journal 13 (1) (2023)
Cristina Correia, Matthew John Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, James R Cerhan, Susan L Slager, Thomas E Witzig, Bruce W Eckloff, Hu Li, Grzegorz S Nowakowski, Scott H Kaufmann
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era. Blood cancer journal 13 (1) (2023)
Suzette J Bielinski, Licy L Yanes Cardozo, Paul Y Takahashi, Nicholas B Larson, Alexandra Castillo, Alana Podwika, Eleanna De Filippis, Valentina Hernandez, Gouri J Mahajan, Crystal Gonzalez, null Shubhangi, Paul A Decker, Jill M Killian, Janet E Olson, Jennifer L St Sauver, Pankaj Shah, Adrian Vella, Euijung Ryu, Hongfang Liu, Gailen D Marshall, James R Cerhan, Davinder Singh, Richard L Summers
Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk Patients. The Journal of clinical endocrinology and metabolism (2023)
Cristina Correia, Matthew John Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, James R Cerhan, Susan L Slager, Thomas E Witzig, Bruce W Eckloff, Hu Li, Grzegorz S Nowakowski, Scott H Kaufmann
Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era. Blood cancer journal 13 (1) (2023)
Juan Pablo Alderuccio, Isildinha M Reis, Jean L Koff, Melissa C Larson, Dai Chihara, Wei Zhao, Sara Haddadi, Thomas M Habermann, Peter Martin, Jennifer Chapman, Christopher S Strouse, Brad S Kahl, Jonathon B Cohen, Jonathan W Friedberg, James R Cerhan, Christopher R Flowers, Izidore S Lossos
Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma. Blood (2023)
Sonja I Berndt, Joseph Vijai, Yolanda Benavente, Nicola J Camp, Alexandra Nieters, Zhaoming Wang, Karin E Smedby, Geffen Kleinstern, Henrik Hjalgrim, Caroline Besson, Christine F Skibola, Lindsay M Morton, Angela R Brooks-Wilson, Lauren R Teras, Charles Breeze, Joshua Arias, Hans-Olov Adami, Demetrius Albanes, Kenneth C Anderson, Stephen M Ansell, Bryan Bassig, Nikolaus Becker, Parveen Bhatti, Brenda M Birmann, Paolo Boffetta, Paige M Bracci, Paul Brennan, Elizabeth E Brown, Laurie Burdett, Lisa A Cannon-Albright, Ellen T Chang, Brian C-H Chiu, Charles C Chung, Jacqueline Clavel, Pierluigi Cocco, Debbie L Bennett, Lucia Conde, David V Conti, David G Cox, Karen Curtin, Delphine Casabonne, Immaculata De Vivo, Arjan Diepstra, W Ryan Diver, Ahmet Dogan, Christopher K Edlund, Lenka Foretova, Joseph F Fraumeni, Attilio Gabbas, Hervé Ghesquières, Graham G Giles, Sally Glaser, Martha Glenn, Bengt Glimelius, Jian Gu, Thomas M Habermann, Christopher A Haiman, Corinne Haioun, Jonathan N Hofmann, Theodore R Holford, Elizabeth A Holly, Amy Hutchinson, Aalin Izhar, Rebecca D Jackson, Ruth F Jarrett, Rudolph Kaaks, Eleanor Kane, Laurence N Kolonel, Yinfei Kong, Peter Kraft, Anne Kricker, Annette Lake, Qing Lan, Charles Lawrence, Dalin Li, Mark Liebow, Brian K Link, Corrado Magnani, Marc Maynadie, James McKay, Mads Melbye, Lucia Miligi, Jonathan Beesley, Thierry J Molina, Alain Monnereau, Rebecca Montalvan, Kari E North, Anne J Novak, Kenan Onel, Mark P Purdue, Kristin A Rand, Elio Riboli, Jacques Riby, Eve Roman, Gilles Andre Salles, Douglas W Sborov, Richard K Severson, Tait D Shanafelt, Martyn T Smith, Alexandra Smith, Kevin W Song, Lei Song, Melissa C Southey, John J Spinelli, Anthony Staines, Deborah Stephens, Heather J Sutherland, Kaitlyn Tkachuk, Carrie A Thompson, Hervé Tilly, Lesley F Tinker, Ruth C Travis, Jenny Turner, Celine M Vachon, Claire M Vajdic, Anke van den Berg, David J Van Den Berg, Roel C H Vermeulen, Paolo Vineis, Sophia S Wang, Elisabete Weiderpass, George J Weiner, Stephanie J Weinstein, Nicole Wong Doo, Yuanqing Ye, Meredith Yeager, Kai Yu, Anne Zeleniuch-Jacquotte, Yawei Zhang, Tongzhang Zheng, Elad Ziv, Joshua Sampson, Nilanjan Chatterjee, Kenneth Offit, Wendy Cozen, Xifeng Wu, James R Cerhan, Stephen J Chanock, Susan L Slager, Nathaniel Rothman
Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia (2023)
Suzette J Bielinski, Licy L Yanes Cardozo, Paul Y Takahashi, Nicholas B Larson, Alexandra Castillo, Alana Podwika, Eleanna De Filippis, Valentina Hernandez, Gouri J Mahajan, Crystal Gonzalez, null Shubhangi, Paul A Decker, Jill M Killian, Janet E Olson, Jennifer L St Sauver, Pankaj Shah, Adrian Vella, Euijung Ryu, Hongfang Liu, Gailen D Marshall, James R Cerhan, Davinder Singh, Richard L Summers
Predictors of Metformin Failure: Repurposing Electronic Health Record Data to Identify High-Risk Patients. The Journal of clinical endocrinology and metabolism (2023)
Paloma García-Martín, Ana Moñiz Díez, José Manuel Sánchez Maldonado, Antonio José Cabrera Serrano, Rob Ter Horst, Yolanda Benavente, Stefano Landi, Angelica Macauda, Alyssa Clay-Gilmour, Francisca Hernández-Mohedo, Yasmeen Niazi, Pedro Antonio González Sierra, Blanca Espinet, Juan José Rodríguez-Sevilla, Rossana Maffei, Gonzalo Blanco, Matteo Giaccherini, Anna Puiggros, James R Cerhan, Roberto Marasca, Marisa Cañadas-Garre, Miguel Ángel López-Nevot, Tzu Hua Chen-Liang, Hauke Thomsen, Irene Gámez, Victor Moreno, Rafael Marcos-Gragera, María García-Álvarez, Javier Llorca, Andrés Jerez, Sonja Berndt, Aleksandra Butrym, Aaron D Norman, Delphine Casabonne, Mario Luppi, Susan L Slager, Kari Hemminki, Yang Li, Miguel Alcoceba, Daniele Campa, Frederico Canzian, Silvia de Sanjosé, Asta Försti, Mihai M Netea, Manuel Jurado, Juan Sainz
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study. Blood cancer journal 12 (5) (2022)
Nansu Zong, Xiaoqian Jiang, Sungrim Moon, Sunyang Fu, Liwei Wang, Yiqing Zhao, Yue Yu, Ming Huang, Yanshan Wang, Gang Zheng, Michelle M Mielke, James R Cerhan, Hongfang Liu
Computational drug repurposing based on electronic health records: a scoping review. NPJ digital medicine 5 (1) (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian L Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew John Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Aung M Tun, Arushi Khurana, Raphael Mwangi, Brian L Link, Yucai Wang, Andrew L Feldman, Carrie A Thompson, Anne J Novak, Jose C Villasboas Bisneto, Gita Thanarajasingam, Umar Farooq, Sergei Syrbu, Grzegorz S Nowakowski, Thomas E Witzig, Stephen M Ansell, Lisa M Rimsza, James R Cerhan, Thomas M Habermann, Matthew John Maurer
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study. Blood advances 6 (17) (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian L Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew John Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Sonja I Berndt, Joseph Vijai, Yolanda Benavente, Nicola J Camp, Alexandra Nieters, Zhaoming Wang, Karin E Smedby, Geffen Kleinstern, Henrik Hjalgrim, Caroline Besson, Christine F Skibola, Lindsay M Morton, Angela R Brooks-Wilson, Lauren R Teras, Charles Breeze, Joshua Arias, Hans-Olov Adami, Demetrius Albanes, Kenneth C Anderson, Stephen M Ansell, Bryan Bassig, Nikolaus Becker, Parveen Bhatti, Brenda M Birmann, Paolo Boffetta, Paige M Bracci, Paul Brennan, Elizabeth E Brown, Laurie Burdett, Lisa A Cannon-Albright, Ellen T Chang, Brian C-H Chiu, Charles C Chung, Jacqueline Clavel, Pierluigi Cocco, Debbie L Bennett, Lucia Conde, David V Conti, David G Cox, Karen Curtin, Delphine Casabonne, Immaculata De Vivo, W Ryan Diver, Ahmet Dogan, Christopher K Edlund, Lenka Foretova, Joseph F Fraumeni, Attilio Gabbas, Hervé Ghesquières, Graham G Giles, Sally Glaser, Martha Glenn, Bengt Glimelius, Jian Gu, Thomas M Habermann, Christopher A Haiman, Corinne Haioun, Jonathan N Hofmann, Theodore R Holford, Elizabeth A Holly, Amy Hutchinson, Aalin Izhar, Rebecca D Jackson, Ruth F Jarrett, Rudolph Kaaks, Eleanor Kane, Laurence N Kolonel, Yinfei Kong, Peter Kraft, Anne Kricker, Annette Lake, Qing Lan, Charles Lawrence, Dalin Li, Mark Liebow, Brian K Link, Corrado Magnani, Marc Maynadie, James McKay, Mads Melbye, Lucia Miligi, Jonathan Beesley, Thierry J Molina, Alain Monnereau, Rebecca Montalvan, Kari E North, Anne J Novak, Kenan Onel, Mark P Purdue, Kristin A Rand, Elio Riboli, Jacques Riby, Eve Roman, Gilles Andre Salles, Douglas W Sborov, Richard K Severson, Tait D Shanafelt, Martyn T Smith, Alexandra Smith, Kevin W Song, Lei Song, Melissa C Southey, John J Spinelli, Anthony Staines, Deborah Stephens, Heather J Sutherland, Kaitlyn Tkachuk, Carrie A Thompson, Hervé Tilly, Lesley F Tinker, Ruth C Travis, Jenny Turner, Celine M Vachon, Claire M Vajdic, Anke van den Berg, David J Van Den Berg, Roel C H Vermeulen, Paolo Vineis, Sophia S Wang, Elisabete Weiderpass, George J Weiner, Stephanie J Weinstein, Nicole Wong Doo, Yuanqing Ye, Meredith Yeager, Kai Yu, Anne Zeleniuch-Jacquotte, Yawei Zhang, Tongzhang Zheng, Elad Ziv, Joshua Sampson, Nilanjan Chatterjee, Kenneth Offit, Wendy Cozen, Xifeng Wu, James R Cerhan, Stephen J Chanock, Susan L Slager, Nathaniel Rothman
Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia 36 (12) (2022)
Susan L Slager, Sameer A Parikh, Sara J Achenbach, Aaron D Norman, Kari G Rabe, Nicholas J Boddicker, Janet E Olson, Geffen Kleinstern, Connie E Lesnick, Timothy G Call, James R Cerhan, Celine M Vachon, Neil E Kay, Esteban Braggio, Curtis A Hanson, Tait D Shanafelt
Progression and survival of MBL: a screening study of 10 139 individuals. Blood 140 (15) (2022)
Sanjal H Desai, Levi D Pederson, Betsy LaPlant, Raphael Mwangi, Matthew John Maurer, Jason R Young, William R Macon, Rebecca L King, Yucai Wang, James R Cerhan, Andrew L Feldman, David J Inwards, Ivana Micallef, Patrick Johnston, Luis F Porrata, Stephen M Ansell, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts. Blood cancer journal 12 (5) (2022)
Juan Pablo Alderuccio, Isildinha M Reis, Thomas M Habermann, Brian K Link, Catherine Thieblemont, Annarita Conconi, Melissa C Larson, Luciano Cascione, Wei Zhao, James R Cerhan, Emanuele Zucca, Izidore S Lossos
Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma. American journal of hematology 97 (12) (2022)
Nicholas J Boddicker, Sara J Achenbach, Sameer A Parikh, Geffen Kleinstern, Esteban Braggio, Aaron D Norman, Kari G Rabe, Celine M Vachon, Connie E Lesnick, Timothy G Call, Janet E Olson, James R Cerhan, Neil E Kay, Curtis A Hanson, Tait D Shanafelt, Susan L Slager
Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis. Leukemia 36 (5) (2022)
Danny Luan, Tolulope Fatola, Ahmed Toure, Christopher R Flowers, Brian L Link, Jonathan W Friedberg, Jonathon B Cohen, Brad S Kahl, Izidore S Lossos, Loretta Nastoupil, Matthew John Maurer, James R Cerhan, Peter Martin
Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis. Blood advances 6 (15) (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian L Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew John Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
James R Cerhan
A (modifiable) way to better Hodgkin lymphoma survivorship? Blood 139 (20) (2022)
Narendranath Epperla, Jeffrey M Switchenko, Veronika Bachanova, James N Gerson, Stefan K Barta, Max J Gordon, Alexey V Danilov, Natalie Sophia Grover, Stephanie P Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T Hill, Nilanjan Ghosh, Steven I Park, David A Bond, Mehdi Hamadani, Timothy S Fenske, Peter Martin, Jin Guo, Mary-Kate Malecek, Brad S Kahl, Christopher R Flowers, Brian L Link, Lawrence D Kaplan, David J Inwards, Andrew L Feldman, Eric D Hsi, Kami Maddocks, Kristie Blum, Nancy L Bartlett, James R Cerhan, John P Leonard, Thomas M Habermann, Matthew John Maurer, Jonathon B Cohen
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma. Blood advances (2022)
Sanjal H Desai, Raphael Mwangi, Wern Lynn Ng, Rebecca L King, Matthew John Maurer, James R Cerhan, Andrew L Feldman, Umar Farooq, Eric Mou, Thomas M Habermann, Carrie A Thompson, Yucai Wang, Thomas E Witzig, Grzegorz S Nowakowski
Increasing tissue requirements in lymphoma trials may exclude patients with high risk disease or worse prognosis. Blood advances (2022)
Sophia S Wang, Claire M Vajdic, Martha S Linet, Susan L Slager, Jenna Voutsinas, Alexandra Nieters, Delphine Casabonne, James R Cerhan, Wendy Cozen, Graciela Alarcón, Otoniel Martinez-Maza, Elizabeth E Brown, Paige M Bracci, Jennifer Turner, Henrik Hjalgrim, Parveen Bhatti, Yawei Zhang, Brenda M Birmann, Christopher R Flowers, Ora Paltiel, Elizabeth A Holly, Eleanor Kane, Dennis D Weisenburger, Marc Maynadié, Pierluigi Cocco, Lenka Foretova, Elizabeth Crabb Breen, Qing Lan, Angela R Brooks-Wilson, Anneclaire J De Roos, Martyn T Smith, Eve Roman, Paolo Boffetta, Anne Kricker, Tongzhang Zheng, Christine F Skibola, Jacqueline Clavel, Alain Monnereau, Stephen J Chanock, Nathaniel Rothman, Yolanda Benavente, Patricia Hartge, Karin E Smedby
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (5) (2022)
Grzegorz S Nowakowski, Matthew John Maurer, James R Cerhan, Debarshi Dey, Laurie Helen Sehn
Utilization of real-world data in assessing treatment effectiveness for diffuse large B-cell lymphoma. American journal of hematology (2022)
Surbhi Sidana, Cristine Allmer, Melissa C Larson, Amylou C Dueck, Kathleen J Yost, Rahma M Warsame, Gita Thanarajasingam, James R Cerhan, Jonas Paludo, S Vincent Rajkumar, Thomas M Habermann, Grzegorz S Nowakowski, Yi Lin, Morie A Gertz, Thomas E Witzig, Angela Dispenzieri, Wilson I Gonsalves, Stephen M Ansell, Carrie A Thompson, Shaji K Kumar
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care. JCO oncology practice 18 (8) (2022)
Sameer A Parikh, Sara J Achenbach, Kari G Rabe, Aaron D Norman, Nicholas J Boddicker, Janet E Olson, Timothy G Call, James R Cerhan, Celine M Vachon, Neil E Kay, Esteban Braggio, Curtis A Hanson, Susan L Slager, Tait D Shanafelt
The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis. Blood cancer journal 12 (11) (2022)
Christopher S Strouse, Melissa C Larson, Shawna L Ehlers, Kathleen J Yost, Matthew John Maurer, Stephen M Ansell, David J Inwards, Patrick B Johnston, Ivana N Micallef, Brian L Link, Umar Farooq, James R Cerhan, Carrie A Thompson
Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis. JCO oncology practice 18 (7) (2022)
Terry Boyle, Geffen Kleinstern, Paige M Bracci, James R Cerhan, Yolanda Benavente, Delphine Casabonne, Brian C-H Chiu, Thomas M Habermann, Elizabeth A Holly, Mark Liebow, Aaron Norman, Ora Paltiel, Dennis Robinson, Nathaniel Rothman, Rania Abu Seir, Susan L Slager, Paul J Villeneuve, Sophia S Wang, Dennis D Weisenburger, John J Spinelli
Physical activity and the risk of non-Hodgkin lymphoma subtypes: A pooled analysis. International journal of cancer (2022)
Alexandra S Higgins, Hidong Kim, Laura Harper, Thomas M Habermann, Grzegorz S Nowakowski, Carrie A Thompson, Patrick Johnston, Thomas E Witzig, Cristine Allmer, Matthew John Maurer, James R Cerhan, Jason R Young, Gita Thanarajasingam
Testicular FDG-PET/CT uptake threshold in aggressive lymphomas. American journal of hematology 96 (3) (2021)
Yucai Wang, Sara J Achenbach, Kari G Rabe, Tait D Shanafelt, Timothy G Call, Wei Ding, Saad Sirop Kenderian, Eli Muchtar, Jose F Leis, Amber B Koehler, Susan M Schwager, James R Cerhan, Susan L Slager, Neil E Kay, Sameer A Parikh
Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index. Blood cancer journal 11 (8) (2021)
Patrizia Mondello, Angelo Fama, Melissa C Larson, Andrew L Feldman, Jose C Villasboas Bisneto, Zhi-Zhang Yang, Ilia Galkin, Viktor Svelolkin, Ekaterina Postovalova, Alexander Bagaev, Pavel Ovcharov, Arina Varlamova, Sarah Huet, Bruno Tesson, Kaitlyn R McGrath, Susan L Slager, Brian K Link, Sergei Syrbu, Anne J Novak, Thomas M Habermann, Thomas E Witzig, Grzegorz S Nowakowski, Gilles Andre Salles, James R Cerhan, Stephen M Ansell
Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma. Blood cancer journal 11 (7) (2021)
Alessia Castellino, Aung Myint Tun, Yucai Wang, Thomas M Habermann, Rebecca L King, Kay M Ristow, James R Cerhan, David J Inwards, Jonas Paludo, Stephen M Ansell, Thomas E Witzig, Grzegorz S Nowakowski
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma. Blood cancer journal 11 (1) (2021)
Geffen Kleinstern, J Brice Weinberg, Sameer A Parikh, Esteban Braggio, Sara J Achenbach, Dennis P Robinson, Aaron D Norman, Kari G Rabe, Nicholas J Boddicker, Celine M Vachon, Connie E Lesnick, Timothy G Call, Danielle M Brander, Laura Z Rassenti, Thomas J Kipps, Janet E Olson, James R Cerhan, Neil E Kay, Richard R Furman, Curtis A Hanson, Tait D Shanafelt, Susan L Slager
Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans. Leukemia (2021)
null Arushi Khurana, Raphael Mwangi, Stephen M Ansell, Thomas M Habermann, James R Cerhan, Christopher Strouse, Brian K Link, Yucai Wang, Rebecca L King, William R Macon, Jose C Villasboas Bisneto, Thomas E Witzig, Matthew John Maurer, Grzegorz S Nowakowski
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era. Blood cancer journal 11 (7) (2021)
Geffen Kleinstern, Melissa C Larson, Stephen M Ansell, Carrie A Thompson, Grzegorz S Nowakowski, Timothy G Call, Dennis P Robinson, Matthew John Maurer, Raphael Mwangi, Andrew L Feldman, Neil E Kay, Anne J Novak, Thomas M Habermann, Susan L Slager, James R Cerhan
Vaccination History and Risk of Lymphoma and Its Major Subtypes. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2021)
Paul Y Takahashi, Euijung Ryu, Suzette J Bielinski, Matthew Hathcock, Gregory D Jenkins, James R Cerhan, Janet E Olson
No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study. Pharmacogenomics and personalized medicine 14 (2021)
Nicholas J Boddicker, Melissa C Larson, Alessia Castellino, Joerg Herrmann, David J Inwards, Gita Thanarajasingam, Matthew John Maurer, Cristine Allmer, Thomas E Witzig, Grzegorz S Nowakowski, Thomas M Habermann, Hector R Villarraga, Susan L Slager, James R Cerhan, Carrie A Thompson
Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era. American journal of hematology 96 (8) (2021)
Joshua C Pritchett, Zhi-Zhang Yang, Hyo Jin Kim, Jose C Villasboas, Xinyi Tang, Shahrzad Jalali, James R Cerhan, Andrew L Feldman, Stephen M Ansell
High-dimensional and single-cell transcriptome analysis of the tumor microenvironment in angioimmunoblastic T cell lymphoma (AITL). Leukemia (2021)
Paul Y Takahashi, Euijung Ryu, James R Cerhan, Suzette J Bielinski, Janet E Olson
Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]. Pharmacogenomics and personalized medicine 14 (2021)
Mark Liebow, Melissa C Larson, Carrie A Thompson, Grzegorz S Nowakowski, Timothy G Call, William R Macon, Neil E Kay, Thomas M Habermann, Susan L Slager, James R Cerhan
Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma. International journal of cancer 149 (3) (2021)
Anneclaire J De Roos, Leah H Schinasi, Lucia Miligi, James R Cerhan, Parveen Bhatti, Andrea 't Mannetje, Dalsu Baris, Yolanda Benavente, Geza Benke, Jacqueline Clavel, Delphine Casabonne, Lin Fritschi, Jonathan N Hofmann, Tran Huynh, Alain Monnereau, Sara Piro, Susan L Slager, Claire M Vajdic, Sophia S Wang, Yawei Zhang, Leslie Bernstein, Pierluigi Cocco
Occupational insecticide exposure and risk of non-Hodgkin lymphoma: A pooled case-control study from the InterLymph Consortium. International journal of cancer 149 (10) (2021)
Caroline Besson, Amy Moore, Wenting Wu, Claire M Vajdic, Silvia de Sanjose, Nicola J Camp, Karin E Smedby, Tait D Shanafelt, Lindsay M Morton, Jerry D Brewer, Lydia Zablotska, Eric A Engels, James R Cerhan, Susan L Slager, Jiali Han, Sonja I Berndt, null null
Common genetic polymorphisms contribute to the association between chronic lymphocytic leukaemia and non-melanoma skin cancer. International journal of epidemiology 50 (4) (2021)
Arushi Khurana, Raphael Mwangi, Grzegorz S Nowakowski, Thomas M Habermann, Stephen M Ansell, Betsy R LaPlant, Brian L Link, James R Cerhan, Matthew John Maurer, Thomas E Witzig
Impact of Organ Function-Based Clinical Trial Eligibility Criteria in Patients With Diffuse Large B-Cell Lymphoma: Who Gets Left Behind? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (15) (2021)
Alessia Castellino, Yucai Wang, Melissa C Larson, Matthew John Maurer, Brian L Link, Umar Farooq, Andrew L Feldman, Sergei I Syrbu, Thomas M Habermann, Jonas Paludo, David J Inwards, Thomas E Witzig, Stephen M Ansell, Cristine Allmer, Susan L Slager, Jonathon B Cohen, Peter Martin, James R Cerhan, Grzegorz S Nowakowski
Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes. Blood advances (2021)
Jordan Edward Krull, Kerstin Wenzl, Keenan T Hartert, Michelle K Manske, Vivekananda Sarangi, Matthew John Maurer, Melissa C Larson, Grzegorz S Nowakowski, Stephen M Ansell, Ellen McPhail, Thomas M Habermann, Brian K Link, Rebecca L King, James R Cerhan, Anne J Novak
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients. Blood cancer journal 10 (11) (2020)
Keenan T Hartert, Kerstin Wenzl, Jordan E Krull, Michelle Manske, Vivekananda Sarangi, Yan Asmann, Melissa C Larson, Matthew John Maurer, Susan Slager, William R Macon, Rebecca L King, Andrew L Feldman, Anita K Gandhi, Brian K Link, Thomas M Habermann, Zhi-Zhang Yang, Stephen M Ansell, James R Cerhan, Thomas E Witzig, Grzegorz S Nowakowski, Anne J Novak
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL. Leukemia 35 (2) (2020)
Linda B Baughn, Zhuo Li, Kathryn Pearce, Celine M Vachon, Mei-Yin Polley, Jonathan J Keats, Eran Elhaik, Michael Baird, Terry Therneau, James R Cerhan, Peter Leif Bergsagel, Angela Dispenzieri, Sundararajan Vincent Rajkumar, Yan W Asmann, Shaji K Kumar
The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias. Blood cancer journal 10 (3) (2020)
Geffen Kleinstern, Nicola J Camp, Sonja I Berndt, Brenda M Birmann, Alexandra Nieters, Paige M Bracci, James D McKay, Hervé Ghesquières, Qing Lan, Henrik Hjalgrim, Yolanda Benavente, Alain Monnereau, Sophia S Wang, Yawei Zhang, Mark P Purdue, Anne Zeleniuch-Jacquotte, Graham G Giles, Roel Vermeulen, Pierluigi Cocco, Demetrius Albanes, Lauren R Teras, Angela R Brooks-Wilson, Claire M Vajdic, Eleanor Kane, Neil E Caporaso, Karin E Smedby, Gilles Salles, Joseph Vijai, Stephen J Chanock, Christine F Skibola, Nathaniel Rothman, Susan L Slager, James R Cerhan
Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29 (5) (2020)
Geffen Kleinstern, Daniel R O'Brien, Xing Li, Shulan Tian, Brian F Kabat, Kari G Rabe, Aaron D Norman, Huihuang Yan, Celine M Vachon, Nicholas J Boddicker, Timothy G Call, Sameer A Parikh, Laura Bruins, Cecilia Bonolo de Campos, Jose F Leis, Tait D Shanafelt, Wei Ding, James R Cerhan, Neil E Kay, Susan L Slager, Esteban Braggio
Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index. American journal of hematology 95 (8) (2020)

James R Cerhan.css-eqlu8i{font-size:small;padding-left:4px;} (James Cerhan)

Publication Activity (10 Years)

Top Topics

Top Venues

James R Cerhan (James Cerhan)